Search

Your search keyword '"M. Yoshimura"' showing total 2 results
Start Over Author "M. Yoshimura" Region europe
2 results on '"M. Yoshimura"'

1. Japanese-Western consensus meeting on biomarkers.

Author

Maisel AS, Nakao K, Ponikowski P, Peacock WF, Yoshimura M, Suzuki T, Tsutamoto T, Filippatos GS, Saito Y, Seino Y, Minamino N, Hirata Y, Mukoyama M, Nishikimi T, and Nagai R

Subjects
Acute Coronary Syndrome blood, Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome therapy, Americas, Atrial Natriuretic Factor blood, Biomarkers blood, Dyspnea etiology, Early Diagnosis, Emergency Service, Hospital, Europe, Heart Diseases therapy, Heart Failure blood, Heart Failure diagnosis, Heart Failure therapy, Humans, Hypertension, Pulmonary therapy, Intensive Care Units, Japan, Myocardial Infarction blood, Myocardial Infarction diagnosis, Myocardial Infarction therapy, Patient Discharge, Practice Guidelines as Topic, Predictive Value of Tests, Prognosis, Survival Rate, Troponin blood, Ventricular Dysfunction, Left blood, Ventricular Dysfunction, Left diagnosis, Ventricular Dysfunction, Left therapy, Dyspnea blood, Heart Diseases blood, Heart Diseases diagnosis, Hypertension, Pulmonary blood, Hypertension, Pulmonary diagnosis, Natriuretic Peptide, Brain blood, Peptide Fragments blood
Published
2011
Full Text
View/download PDF

2. Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies.

Author

Ishikawa T, Nakano Y, Endoh A, Kubota T, Suzuki T, Nakata K, Miyamoto T, Murakami M, Sakamoto H, Imai K, Mochizuki S, Yoshimura M, and Mutoh M

Subjects
Acute Coronary Syndrome therapy, Angina, Unstable therapy, Europe epidemiology, Humans, Incidence, Japan epidemiology, Paclitaxel, Retrospective Studies, Sirolimus, Thrombosis prevention & control, United States epidemiology, Clinical Trials as Topic, Drug-Eluting Stents adverse effects, Platelet Aggregation Inhibitors administration & dosage, Thrombosis epidemiology, Thrombosis etiology, Ticlopidine administration & dosage
Abstract

Background and Objectives: The incidence of definite stent thrombosis (ST) after use of drug-eluting stents (DES), as defined by the Academic Research Consortium, is known to be lower in Japan than in western countries. However, a statistical difference in the incidence of early definite ST (EDST) associated with the unrestricted use of DES has not yet been documented. Therefore, the incidence of EDST in our Japanese institute after unrestricted use of DES was retrospectively compared with those reported in western mega-studies., Methods and Results: During the 40 months from August 2004 to November 2007 (before approval of clopidogrel in Japan), DES were implanted in 3605 lesions in 1885 patients in our institute; lesion- and patient-associated percentages of DES use were 95.2% and 94.7%, respectively. Mean stent length per lesion was 33.2 mm, emergent procedures and ST-elevation myocardial infarctions made up 33.7% and 16.4% of the procedures, respectively, intravascular ultrasonography was used 96.0% of the time, a distal protection device for acute coronary syndrome was used 68.7% of the time, and the mean maximum inflation pressure was 19.5 atm. EDST was observed in five lesions (0.139%) in four patients (0.212%). The incidence of patient-associated EDST at our center was significantly lower than in four western mega-studies (0.736%, 66 of 8970 patients; 0.634%, 149 of 23,500; 0.595%, 52 of 8402; 0.997%, 20 of 2006) (p<0.05, <0.01, <0.05, <0.01, respectively, using a chi(2)-test)., Conclusion: Due to differences in procedural approaches in Japan, the incidence of EDST after unrestricted use of DES was significantly lower than in western countries.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results